Epoxylipids and soluble epoxide hydrolase in heart diseases.
Epoxylipids and soluble epoxide hydrolase in heart diseases.
复制标题
DOI:
10.1016/j.bcp.2021.114866
复制
发表时间:
2022-01
影响因子:
5.8
通讯作者:
Neckar J
中科院分区:
文献类型:
--
作者:
Imig JD;Cervenka L;Neckar J
Cardiovascular and heart diseases are leading causes of morbidity and mortality. Coronary artery endothelial and vascular dysfunction, inflammation, and mitochondrial dysfunction contribute to progression of heart diseases such as arrhythmias, congestive heart failure, and heart attacks. Classes of fatty acid epoxylipids and their enzymatic regulation by soluble epoxide hydrolase (sEH) have been implicated in coronary artery dysfunction, inflammation, and mitochondrial dysfunction in heart diseases. Likewise, genetic and pharmacological manipulations of epoxylipids have been demonstrated to have therapeutic benefits for heart diseases. Increasing epoxylipids reduce cardiac hypertrophy and fibrosis and improve cardiac function. Beneficial actions for epoxylipids have been demonstrated in cardiac ischemia reperfusion injury, electrical conductance abnormalities and arrhythmias, and ventricular tachycardia. This review discusses past and recent findings on the contribution of epoxylipids in heart diseases and the potential for their manipulation to treat heart attacks, arrhythmias, ventricular tachycardia, and heart failure.
登录
查看更多内容
影响因子:
7.3
作者:
Falck JR;Koduru SR;Mohapatra S;Manne R;Atcha KR;Atcha R;Manthati VL;Capdevila JH;Christian S;Imig JD;Campbell WB
通讯作者:
Campbell WB
影响因子:
2.1
作者:
Červenka L;Melenovský V;Husková Z;Sporková A;Bürgelová M;Škaroupková P;Hwang SH;Hammock BD;Imig JD;Sadowski J
通讯作者:
Sadowski J
影响因子:
7.3
作者:
Batchu, S. N.;Lee, S. B.;Seubert, J. M.
通讯作者:
Seubert, J. M.
影响因子:
3
作者:
Chaudhary KR;Abukhashim M;Hwang SH;Hammock BD;Seubert JM
通讯作者:
Seubert JM
影响因子:
5
作者:
Batchu, Sri N.;Chaudhary, Ketul R.;Seubert, John M.
通讯作者:
Seubert, John M.